Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

0.7940 +0.0618 (+8.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics Inc

< Previous 1 2 3 4 5 6 7 Next >
Bionano Genomics' Next-Gen Platform Set to Boost Throughput by 13x: Future of Cytogenetic Analysis Underway
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
 
Via Benzinga
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.
Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities. 
Via InvestorPlace
Porch Group And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Recap: Bionano Genomics Q1 Earnings
 
Via Benzinga
Earnings Outlook For Bionano Genomics
 
Via Benzinga
Why Shares of Bionano Genomics Are Up Monday
The life sciences company said it expects another improved quarter of revenue. 
Via The Motley Fool
Earnings Preview: Bionano Genomics
 
Via Benzinga
3 Growth Stocks That Are Disrupting Their Industries in 2023
With many extremely powerful technologies proliferating, it's easer than ever to find disruptive growth stock winners. 
Via InvestorPlace
Bionano Genomics (BNGO) Q1 2023 Earnings Call Transcript
BNGO earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
This is a classic matchup of a grizzled top dog against a scrappy competitor. 
Via The Motley Fool
7 Growth Stocks With Huge Return Potential for Long-Term Investors
Overdone worries about a recession are poised to disappear, causing many excellent growth stocks to soar in the coming months. 
Via InvestorPlace
7 Stocks That Could Skyrocket in the Next 12 Months
With the macro environment becoming excellent and much of the Street starting to turn bullish, it's time to find superb stocks to buy. 
Via InvestorPlace
Is Bionano Genomics Stock a Buy Now?
Revenue growth is likely on the way, but the stock price doesn't reflect that potential. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
Moderna, Roblox, State Street And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Dow Jones dropping over 25 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday. 
Via Benzinga
3 Supercharged Growth Stocks With 662% to 741% Upside, According to Wall Street
These fast-paced stocks are on the cutting edge of innovation, and select Wall Street analysts and pundits expect them to skyrocket. 
Via The Motley Fool
The 3 Most Promising Penny Stocks to Buy in April
Here are three of the most promising penny stocks from some of the most popular growth sectors emerging in 2023 
Via InvestorPlace
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Buy This Magnificent Growth Stock Before It's Too Late
Bionano is gaining momentum and could soon be approaching escape velocity. 
Via The Motley Fool
Is Bionano Genomics a Risk Worth Taking at This Price?
Revenues are increasing, but with its meme stock heyday well in the rearview mirror, it's fair to ask whether Bionano Genomics stock is a risk worth taking 
Via MarketBeat
Stocks React To February Jobs Report: The Winners And Losers
The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors. 
Via Benzinga
Bionano Genomics (BNGO) Q4 2022 Earnings Call Transcript
BNGO earnings call for the period ending December 31, 2022. 
Via The Motley Fool
BioNano Genomics Reports Q4 Beat, Issues FY23 Guidance: What Investors Need To Know
BioNano Genomics Inc (NASDAQ: BNGO) shares are trading marginally lower during Thursday's after-hours session after the company reporte 
Via Benzinga
This Growth Stock Is Down 38% and Wall Street Says It's Worth Buying Hand Over Fist
With no recent stumbles and more growth on the way, buying shares now could be a smart move. 
Via The Motley Fool
7 Stocks to Buy on Weakness While You Can
The American economy is very strong, so investors should look for good stocks to buy on weakness at this point. 
Via InvestorPlace
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023
Both have growth catalysts on the way, and plenty of recurring revenue too. 
Via The Motley Fool
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
These cutting-edge biotech companies quickly fell out of favor with investors this week. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.